Bayard Powell to Neoplasms
This is a "connection" page, showing publications Bayard Powell has written about Neoplasms.
Connection Strength
0.276
-
Duckworth KE, Morrell R, Russell GB, Powell B, Canzona M, Lichiello S, Riffle O, Tolbert A, McQuellon R. Goals and Adverse Effects: Rate of Concordance Between Patients and Providers. J Oncol Pract. 2019 09; 15(9):e798-e806.
Score: 0.112
-
Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED, D'Agostino RB, Petro RM, Blackstock W, Powell BL, Abraham E, Pasche B, Zhang W. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. J Hematol Oncol. 2017 05 04; 10(1):100.
Score: 0.096
-
Frankel AE, Powell BL, Duesbery NS, Vande Woude GF, Leppla SH. Anthrax fusion protein therapy of cancer. Curr Protein Pept Sci. 2002 Aug; 3(4):399-407.
Score: 0.035
-
Frankel AE, Powell BL, Lilly MB. Diphtheria toxin conjugate therapy of cancer. Cancer Chemother Biol Response Modif. 2002; 20:301-13.
Score: 0.033